1. Home
  2. PKOH vs ABEO Comparison

PKOH vs ABEO Comparison

Compare PKOH & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$24.28

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.05

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
ABEO
Founded
1907
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
280.2M
IPO Year
N/A
1980

Fundamental Metrics

Financial Performance
Metric
PKOH
ABEO
Price
$24.28
$5.05
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$18.20
AVG Volume (30 Days)
20.8K
1.3M
Earning Date
03-04-2026
03-19-2026
Dividend Yield
2.06%
N/A
EPS Growth
30.26
N/A
EPS
1.68
1.29
Revenue
$1,592,500,000.00
$400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.72
$1,589.77
P/E Ratio
$14.43
$4.10
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$3.93
52 Week High
$26.31
$7.54

Technical Indicators

Market Signals
Indicator
PKOH
ABEO
Relative Strength Index (RSI) 65.99 47.26
Support Level $21.17 $4.79
Resistance Level $24.00 $5.42
Average True Range (ATR) 0.90 0.28
MACD 0.14 -0.01
Stochastic Oscillator 88.27 31.26

Price Performance

Historical Comparison
PKOH
ABEO

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: